Given a BUN of 93 mg/dL and a serum creatinine of 1.85 mg/dL, which intravenous fluid should be initiated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Initiate Balanced Crystalloids (Lactated Ringer's or Plasmalyte)

For a patient with BUN 93 mg/dL and creatinine 1.85 mg/dL indicating acute kidney injury, you should start balanced crystalloids such as Lactated Ringer's or Plasmalyte rather than 0.9% normal saline. 1

Clinical Context and Rationale

Your patient's BUN:Creatinine ratio is approximately 50:1 (93/1.85), which is markedly elevated above the normal 10-20:1 range. While traditionally this elevated ratio suggested "pre-renal" azotemia, recent evidence shows this distinction is clinically misleading 2. Patients with elevated BUN:Cr ratios actually have higher mortality (odds ratio 5.73 vs 3.32 for low ratios), contradicting the old teaching that "pre-renal" disease is more benign 2.

Fluid Selection Algorithm

First-Line: Balanced Crystalloids

  • Use Lactated Ringer's or Plasmalyte as your initial resuscitation fluid
  • These solutions reduce major adverse kidney events (death, dialysis initiation, or persistent creatinine doubling) with OR 0.80 (95% CI 0.67-0.94) compared to normal saline 1
  • They demonstrate a trend toward lower in-hospital mortality (OR 0.80,95% CI 0.67-0.97) 1
  • The renal protective effect is most pronounced when initiated early in the emergency department rather than delayed until ICU admission 1

Why NOT Normal Saline (0.9% NaCl)

  • High chloride content from large-volume normal saline administration (>5000 mL) increases mortality and worsens renal function 1
  • Consistently associated with worse acid-base balance 1
  • The hyperchloremic metabolic acidosis from normal saline can worsen renal perfusion

Albumin Consideration

Do not use albumin as first-line therapy 1. While the 2021 Surviving Sepsis Campaign suggested albumin addition for septic patients requiring large volumes, the 2022 expert guidelines found insufficient evidence to recommend it 1. The CRYCO study even suggested potential harm to renal function with 20% albumin in shock patients 1.

Critical Clinical Caveats

Volume Assessment First

Before initiating any IV fluid:

  • Assess volume status clinically: Check for hypotension, tachycardia, orthostatic changes, decreased skin turgor, dry mucous membranes
  • Determine if fluid is indicated: Not all AKI requires aggressive volume resuscitation
  • If the patient is euvolemic or hypervolemic, IV fluids may worsen outcomes

Specific Scenarios

If sepsis/septic shock is present:

  • Balanced crystalloids are GRADE 2+ recommended specifically for this population 1
  • The mortality and renal benefit is most robust in septic patients

If hemorrhagic shock:

  • Still prefer balanced crystalloids over normal saline (GRADE 2+) 1
  • Avoid hypertonic saline (3% or 7.5%) - it shows no mortality benefit (GRADE 1-) 1

If heart failure is suspected:

  • The elevated BUN:Cr ratio in heart failure patients identifies high-risk individuals who may show transient improvement with treatment but remain at substantially increased mortality risk (hazard ratio 2.2) 3
  • Consider diuretics rather than volume expansion if volume overloaded

Monitoring Parameters

After initiating balanced crystalloids, monitor:

  • Urine output (target >0.5 mL/kg/hr)
  • Serial creatinine and BUN at 24-48 hours
  • Hemodynamic response (blood pressure, heart rate)
  • Electrolytes, particularly potassium (Lactated Ringer's contains 4 mEq/L potassium)

Common Pitfall to Avoid

Do not reflexively give large volumes of fluid based solely on elevated BUN:Cr ratio. The elevated ratio does NOT reliably indicate volume-responsive "pre-renal" disease 2. Instead, it identifies patients at higher mortality risk who require careful assessment of actual volume status before fluid administration. Inappropriate fluid overload in these patients can precipitate pulmonary edema and worsen outcomes.

Related Questions

In a 76-year-old patient with a serum creatinine of 0.56 mg/dL and a BUN/creatinine ratio of 23, what is the appropriate management?
What is the likely diagnosis and recommended management for a patient with an elevated blood urea nitrogen and a high BUN-to-creatinine ratio?
What does the fluctuating serum creatinine (1.33 → 1.11 → 1.31 mg/dL) and blood urea nitrogen (20 → 13 → 16 mg/dL) across three visits, including two emergency department visits, indicate about my renal function?
How should I manage a patient with an elevated blood urea nitrogen (BUN) and a BUN-to-creatinine ratio greater than 20:1?
What upper gastrointestinal conditions should be considered in a patient with an elevated blood urea nitrogen (BUN) and a BUN-to-creatinine ratio ≥22?
In a low‑risk patient with febrile neutropenia, what outpatient oral antimicrobial regimen is recommended?
What is the mechanism of action of sildenafil?
What is the significance of a gallbladder that is completely filled with biliary sludge, and what management is recommended?
Is amoxicillin‑clavulanate 625 mg three times daily together with ciprofloxacin 500 mg twice daily an appropriate outpatient regimen for a low‑risk febrile neutropenic patient?
How can CO₂ retention be cleared (blown off) using BiPAP (bilevel positive airway pressure)?
As a senior consultant physician and clinical pharmacology expert, can you provide a comprehensive, evidence‑based algorithm for diagnosing and prescribing systemic hypertension treatment for a junior doctor in an Indian government hospital outpatient department, covering BP classification, measurement, investigations, when to start medication versus lifestyle changes, first‑line drug choices with exact starting and maximum doses, stepwise escalation (monotherapy, dual, triple, resistant), drug selection based on age, diabetes, CKD, heart failure, CAD, pregnancy and other comorbidities, contraindications, adverse effects, monitoring, management of hypertensive urgency and emergency, follow‑up schedule, sample prescriptions, common Indian drug combinations, and pitfalls to avoid?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.